person
as of 2026-07-01Philip Gerretsen, MD, PhD
at a glance
Roles: Principal Investigator, Author, Investigator+Author
KOL signal score 15
3 publications · 3 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Centre for Addiction and Mental Health
Roles
Principal Investigator, Author, Investigator+Author
KOL signal
15
Publications
3 (3 high-value)
Trial investigator
yes
Publishes on
1 drugs
Trials led
5
The Effects of tDCS on Illness Awareness in Schizophrenia
NCT02848885—Completed
The Effects of Non-invasive Neuromodulation on Illness Awareness in Schizophrenia
NCT05957484—Terminated
Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia
NCT05435300—Recruiting
Reactivity of the Vestibular System to Caloric Vestibular Stimulation in Schizophrenia
NCT03048370—Completed
The Effects of Non-invasive Brain Stimulation on Treatment Adherence in Schizophrenia
NCT04033679—Recruiting
Publications & congress
3
Virtual Reality for the Treatment of Auditory Hallucinations in Schizophrenia Spectrum Disorders: a Systematic Review and Meta-Analysis.
Schizophrenia bulletin · 2026 · high-value
The Immediate and Sustained Effects of Multi-Session Biparietal Transcranial Direct Current Stimulation on Insight in Schizophrenia.
Schizophrenia bulletin · 2026 · high-value
The effect of second-generation antipsychotics on anxiety/depression in patients with schizophrenia: A systematic review and meta-analysis.
Schizophrenia research · 2024 · high-value
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on
drug
PRINCIPAL_INVESTIGATOR